AXGN (STOCKS)
Axogen, Inc. Common Stock
$33.322200
+1.362200 (+4.26%)
Prev close: $31.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael D. Dale
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,735.98M
- Employees
- 452
- P/E (TTM)
- -98.82
- P/B (TTM)
- 11.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.07 | $0.10 | -0.0291 | -29.36% |
|
Sep 2025 (Q3)
|
$0.12 | $0.07 | +0.0469 | +64.16% |
|
Jun 2025 (Q2)
|
$0.12 | $0.06 | +0.0554 | +85.76% |
|
Mar 2025 (Q1)
|
$-0.02 | $0.02 | -0.0363 | -222.70% |
Financial Statements
| Revenues | $225.21M |
| Benefits Costs and Expenses | $175.20M |
| Cost Of Revenue | $57.86M |
| Costs And Expenses | $175.20M |
| Gross Profit | $167.35M |
| Nonoperating Income/Loss | -$7.85M |
| Operating Expenses | $175.20M |
| Research and Development | $32.89M |
| Other Operating Expenses | $142.32M |
| Operating Income/Loss | -$7.85M |
| Income/Loss From Continuing Operations After Tax | -$15.70M |
| Income/Loss From Continuing Operations Before Tax | $50.01M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$15.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.34 |
| Diluted Earnings Per Share | -$0.34 |
| Basic Average Shares | 46,050,266 |
| Diluted Average Shares | 46,050,266 |
| Assets | $221.69M |
| Current Assets | $120.42M |
| Inventory | $42.37M |
| Other Current Assets | $78.05M |
| Noncurrent Assets | $101.27M |
| Intangible Assets | $6.75M |
| Other Non-current Assets | $94.52M |
| Liabilities | $92.84M |
| Current Liabilities | $23.56M |
| Accounts Payable | $2.89M |
| Other Current Liabilities | $20.67M |
| Noncurrent Liabilities | $69.28M |
| Long-term Debt | $48.39M |
| Other Non-current Liabilities | $20.90M |
| Equity | $128.85M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $128.85M |
| Liabilities And Equity | $221.69M |
| Net Cash Flow From Operating Activities | $812.00K |
| Net Cash Flow From Operating Activities, Continuing | $812.00K |
| Net Cash Flow From Investing Activities | -$5.32M |
| Net Cash Flow From Investing Activities, Continuing | -$5.32M |
| Net Cash Flow From Financing Activities | $10.50M |
| Net Cash Flow From Financing Activities, Continuing | $10.50M |
| Net Cash Flow | $5.99M |
| Net Cash Flow, Continuing | $5.99M |
| Comprehensive Income/Loss | -$15.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.70M |
| Other Comprehensive Income/Loss | $0.00 |